{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:24:55Z","timestamp":1793283895455,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.drudis.2007.07.008","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T07:27:52Z","timestamp":1188286072000},"page":"748-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["PET tracers for 5-HT1A receptors and uses thereof"],"prefix":"10.1016","volume":"12","author":[{"given":"J.S. Dileep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. John","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2007.07.008_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT1A receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drudis.2007.07.008_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0024-3205(02)02482-7","article-title":"Regulation of 5-HT1A receptor functions in brain following agonist or antidepressant administration","volume":"72","author":"Hensler","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2007.07.008_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","article-title":"Reduced serotonin type 1A receptor binding in panic disorder","volume":"24","author":"Neumeister","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2007.07.008_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0893-133X(01)00310-4","article-title":"Serotonin1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims","volume":"25","author":"Arango","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3956(03)00048-7","article-title":"Genetics of the serotonergic system in suicidal behavior","volume":"37","author":"Arango","year":"2003","journal-title":"J. Psychiatric Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biopsych.2005.05.006","article-title":"Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety","volume":"58","author":"Sullivan","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/brain\/awh109","article-title":"5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study","volume":"127","author":"Merlet","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2007.07.008_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.biopsych.2003.12.016","article-title":"Brain serotonin1A receptor binding in bulimia nervosa","volume":"55","author":"Tiihonen","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1073\/pnas.0510237103","article-title":"Serotonin1A receptors in the living brain of Alzheimer's disease patients","volume":"103","author":"Kepe","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.drudis.2007.07.008_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-2160-3","article-title":"Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers","volume":"180","author":"Kuenzel","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(03)02554-X","article-title":"Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease","volume":"974","author":"Lai","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0197-0186(96)00124-6","article-title":"[3H]WAY100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia","volume":"30","author":"Burnet","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.drudis.2007.07.008_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","article-title":"Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY100635 and [11C]WAY100635","volume":"745","author":"Hall","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(95)00523-S","article-title":"Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims","volume":"688","author":"Arango","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2005.06.016","article-title":"Altered serotonin 1A binding in major depression: a [carbonyl-11C]WAY100635 Positron Emission Tomography Study","volume":"59","author":"Parsey","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(02)03243-2","article-title":"Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [11C]WAY100635","volume":"954","author":"Parsey","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0969-8051(00)00110-4","article-title":"Radioligands for the study of brain 5-HT1A receptors: in vivo development of some new analogues of WAY","volume":"27","author":"Pike","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0969-8051(00)00109-8","article-title":"A retrospect on the discovery of WAY100635 and the prospect for improved 5-HT1A receptor PET radioligands","volume":"27","author":"Cliff","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0079-6468(08)70094-8","article-title":"Radioligands for the study of brain 5-HT1A receptors in vivo","volume":"38","author":"Pike","year":"2001","journal-title":"Progr. Med. Chem."},{"key":"10.1016\/j.drudis.2007.07.008_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002590000394","article-title":"Visualization of serotonin-1A (5-HT1A) receptors in the central nervous system","volume":"28","author":"Pashchier","year":"2001","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(94)01416-F","article-title":"Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist","volume":"673","author":"Khawaja","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0922-4106(95)90192-2","article-title":"The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes","volume":"288","author":"Gozlan","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.07.008_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0969-8051(96)00061-3","article-title":"Characterisation of the radioactive metabolites of the 5-HT1A receptorradioligand, [O-methyl-11C]WAY1000635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET","volume":"23","author":"Osman","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","article-title":"Autoradiographic localization of 5-HT1A receptors in the postmortem human brain using [3H]WAY-100635 and [11C]WAY100635","volume":"745","author":"Hall","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib26","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1523\/JNEUROSCI.18-18-07394.1998","article-title":"Increase in serotonin1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity","volume":"18","author":"Stockmeier","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2007.07.008_bib27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)03211-X","article-title":"Gender-specific aging effects on the serotonin1A receptor","volume":"895","author":"Meltzer","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1006\/nimg.2001.0984","article-title":"A database of [11C]WAY100635 binding to 5-HT1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables","volume":"15","author":"Rabiner","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.drudis.2007.07.008_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0893-133X(00)00227-X","article-title":"Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY100635 and PET","volume":"24","author":"Tauscher","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY 100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib32","first-page":"1","article-title":"Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans","volume":"30","author":"M\u00f8ller","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00004647-200007000-00011","article-title":"Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY100635 in humans: Comparison of arterial and reference tissue input functions","volume":"20","author":"Parsey","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.drudis.2007.07.008_bib34","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.npp.1300556","article-title":"Serotonin1A receptor binding and treatment response in late-life depression","volume":"29","author":"Meltzer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0006-3223(01)01205-7","article-title":"PET measurement of the influence of corticosteroids on serotonin1A receptor number","volume":"50","author":"Montgomery","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib36","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2006.05.022","article-title":"Reduced serotonin1A receptor binding in social anxiety disorder","volume":"61","author":"Lanzenberger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(01)03297-8","article-title":"Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study","volume":"927","author":"Price","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/01.WNL.0000123696.98166.AF","article-title":"Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy","volume":"62","author":"Savic","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2007.07.008_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eplepsyres.2006.09.003","article-title":"Changes in central 5-HT1A receptor binding in mesial temporal epilepsy measured by positron emission tomography with [11C]WAY100635","volume":"73","author":"Ito","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drudis.2007.07.008_bib41","first-page":"946","article-title":"Regional reductions in serotonin1A receptor binding in juvenile myoclonic epilepsy","volume":"62","author":"Meschakes","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.drudis.2007.07.008_bib42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.62.9.1032","article-title":"Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl-11C]WAY100635","volume":"62","author":"Bailer","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pscychresns.2006.05.002","article-title":"A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria","volume":"148","author":"Jovanovic","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.drudis.2007.07.008_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0006-3223(97)00321-1","article-title":"Alterations in the cortical serotonergic system in schizophrenia: a postmortem study","volume":"42","author":"Gurevich","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0024-3205(91)90556-Q","article-title":"Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia","volume":"48","author":"Hashimoto","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2007.07.008_bib46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0006-3223(95)00026-7","article-title":"Autoradiography with [3H]8-OH-DPAT reveals I increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia","volume":"39","author":"Simpson","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archpsyc.59.6.514","article-title":"Brain Serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY100635","volume":"59","author":"Tauscher","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2003.11.016","article-title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia","volume":"55","author":"Yasuno","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-006-0543-8","article-title":"Serotonin1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY100635","volume":"189","author":"Frankle","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biopsych.2004.10.031","article-title":"Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY100635","volume":"57","author":"Cleare","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","article-title":"Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY100635 PET study","volume":"25","author":"Doder","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2007.07.008_bib53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/brain\/awh428","article-title":"[11C]WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS","volume":"128","author":"Turner","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2007.07.008_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/026988110401800304","article-title":"A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment","volume":"18","author":"Bantick","year":"2004","journal-title":"J. Psychopharmacol"},{"key":"10.1016\/j.drudis.2007.07.008_bib55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0893-133X(99)00125-6","article-title":"PET-determination of robalzotan (NAD-299) induced 5-HT1A receptor occupancy in the monkey brain","volume":"22","author":"Farde","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib56","doi-asserted-by":"crossref","unstructured":"Passchier, J. et al. (2001) Quantifying drug-related 5-HT1A receptor occupancy with J Psychopharmacology, 155, 193\u2013197","DOI":"10.1007\/s002130100688"},{"key":"10.1016\/j.drudis.2007.07.008_bib57","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/appi.ajp.158.12.2080","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low","volume":"158","author":"Rabiner","year":"2001","journal-title":"Am. J Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0893-133X(00)00187-1","article-title":"Differential occupancy of somatodendritic and postsynaptic 5-HT1A receptors by pindolol. A dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans","volume":"24","author":"Martinez","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib59","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/jpet.301.3.1144","volume":"301","author":"Rabiner","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2007.07.008_bib60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.npp.1300390","article-title":"Occupancy of agonist drugs at the 5-HT1A receptor","volume":"29","author":"Bantick","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(00)00120-7","article-title":"Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY100635","volume":"27","author":"Rabiner","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002590050230","article-title":"[Carbonyl-11C]Desmethyl-WAY100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo","volume":"25","author":"Pike","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib63","first-page":"292","article-title":"The PET radioligand [carbonyl-11C]desmethyl-WAY-100635 binds to 5-HT1A receptors and provides a higher radioactive signal than [carbonyl-11C]WAY-100635 in the human brain","volume":"43","author":"Andree","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib64","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0969-8051(99)00056-6","article-title":"An improved one-pot procedure for the preparation of [11C-carbonyl]WAY100635","volume":"26","author":"Hwang","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib65","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apradiso.2004.10.005","article-title":"Synthesis procedure for routine production of [carbonyl-11C]desmethyl-WAY-100635","volume":"62","author":"Maiti","year":"2005","journal-title":"Appl. Rad. Isotop."},{"key":"10.1016\/j.drudis.2007.07.008_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1098-2396(199702)25:2<147::AID-SYN5>3.0.CO;2-C","article-title":"p-[18F]MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans","volume":"25","author":"Shiue","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuropharm.2006.09.023","article-title":"[18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain","volume":"52","author":"Aznavour","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2007.07.008_bib68","first-page":"1495","article-title":"A reduced extracellular serotonin level increases the 5-HT1A PET ligand [18F]MPPF binding in the rat hippocampus","volume":"44","author":"Zimmer","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/syn.10235","article-title":"Displacement of the PET ligand [18F]MPPF by the electrically evoked serotonin release in the rat hippocampus","volume":"49","author":"Rbah","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib70","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00259-002-0866-6","article-title":"The potential of the \u03b2-microprobe, an intracerebral radiosensitive probe, to monitor the [18F]MPPF binding in the rat dorsal raphe nucleus","volume":"29","author":"Zimmer","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.drudis.2007.07.008_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/syn.20209","article-title":"Effect of fenfluramine-induced increases in serotonin release on [[18F]MPPF binding: a continuous infusion PET study in conscious monkeys","volume":"59","author":"Udo De Haes","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.biopsych.2004.07.018","article-title":"Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [18F]MPPF positron emission tomography study","volume":"56","author":"Praschak","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib73","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/syn.10134","article-title":"5-HT1A receptor imaging in the human brain: effect of tryptophan depletion and infusion on [18F]MPPF binding","volume":"46","author":"Udo De Haes","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jchemneu.2006.01.006","article-title":"A comparison of in vivo and in vitro neuroimaging of 5-HT1A receptor binding sites in the cat brain","volume":"31","author":"Aznavour","year":"2006","journal-title":"J. Chem. Neuroanatomy"},{"key":"10.1016\/j.drudis.2007.07.008_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuroimage.2005.09.052","article-title":"Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy","volume":"30","author":"Derry","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.drudis.2007.07.008_bib76","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.nucmedbio.2006.03.010","article-title":"Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats","volume":"33","author":"Defraiteur","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib77","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.bmc.2006.01.064","article-title":"Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635","volume":"14","author":"Lang","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2007.07.008_bib78","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","article-title":"Reduced serotonin type1A receptor binding in panic disorder","volume":"24","author":"Neumeister","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2007.07.008_bib79","first-page":"1128","article-title":"5-HT1A receptors are reduced in temporal lobe epilepsy after partial-volume correction","volume":"46","author":"Giovacchini","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib80","first-page":"749","article-title":"PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy","volume":"11","author":"Tozeck","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2007.07.008_bib81","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1528-1167.2006.00458.x","article-title":"The effect of antiepileptic drugs on 5-HT1A receptor binding measured by positron emission tomography","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2007.07.008_bib82","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1176\/appi.ajp.162.2.383","article-title":"No change in serotonin type1A receptor binding in patients with posttraumatic stress disorder","volume":"162","author":"Bonne","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drudis.2007.07.008_bib83","first-page":"345","article-title":"PET imaging of brain 5-HT1A receptors in rat in vivo with [18F]FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole","volume":"47","author":"Tipre","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib84","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0969-8051(00)00112-8","article-title":"Imaging the 5-HT1A receptors with PET: WAY100635 and analogues","volume":"27","author":"Houle","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib85","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/00006231-199712000-00004","article-title":"Imaging 5-HT1A receptors with positron emission tomography: initial human studies with [11C]CPC-222","volume":"18","author":"Houle","year":"1997","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.drudis.2007.07.008_bib86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11307-005-4127-5","article-title":"Two C-methyl derivatives of [11C]WAY100635-effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey","volume":"7","author":"McCarron","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib87","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/syn.20327","article-title":"Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(\u2212)-RWAY","volume":"60","author":"Yasuno","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib88","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.20348","article-title":"Effect of a P-glycoprotein inhibitor, cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand [11C](R)-(\u2212)-RWAY","volume":"61","author":"Liow","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib89","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/syn.20392","article-title":"Quantification of serotonin 5-HT1A receptors in humans with [11C](R)-(2)-RWAY: radiometabolite(s) likely confound brain measurements","volume":"61","author":"Zhang","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.drudis.2007.07.008_bib90","first-page":"1697","article-title":"Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, [18F]-labeled mefway, in rodents and imaging by PET in a nonhuman primate","volume":"47","author":"Saigal","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/bioo.1998.1089","article-title":"Synthesis and biodistribution of (R,S)-[O-methyl-11C]1-[3-(5-methoxy-1,2,3,4-tetrahydro-1-naphthalenyl)propyl]-4-phenylpiperazine (PNU-157760), a putative radioligand for 5-HT1A receptors","volume":"26","author":"Matarrese","year":"1998","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.drudis.2007.07.008_bib92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jlcr.924","article-title":"Synthesis and biological evaluation of S-[11C]methylated mercaptoimidazole piperazinyl derivatives as potential radioligands for imaging 5-HT1A receptors by positron emission tomography(PET)","volume":"48","author":"Garcia","year":"2005","journal-title":"J. Label. Compd. Radiopham."},{"key":"10.1016\/j.drudis.2007.07.008_bib93","doi-asserted-by":"crossref","first-page":"12930","DOI":"10.1021\/bi970112b","article-title":"Human 5-HT1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells","volume":"36","author":"Clawges","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2007.07.008_bib94","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.bjp.0703394","article-title":"5-HT1A receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems","volume":"130","author":"Watson","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.07.008_bib95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0922-4106(95)90192-2","article-title":"The selective 5-HT1A antagonist radioligand [3H]WAY100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes","volume":"288","author":"Gozlan","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.07.008_bib96","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3565(25)24460-3","article-title":"125I-bolton-hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies","volume":"244","author":"Gozlan","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2007.07.008_bib97","first-page":"147","article-title":"[125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system","volume":"306","author":"Ponchant","year":"1988","journal-title":"C R Acad. Sci. III"},{"key":"10.1016\/j.drudis.2007.07.008_bib98","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/jm00073a016","article-title":"Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3\u2032-iodo-2\u2032-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand","volume":"36","author":"Zhuang","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2007.07.008_bib99","first-page":"S675","article-title":"Preparation of [propyl-11C]OSU 191, a highly potent and selective 5-HT1A agonist for PET","volume":"35","author":"Halldin","year":"1994","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib100","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0024-3205(98)00420-2","article-title":"In vivo biodistribution of a radiotracer for imaging serotonin-1A receptor sites with PET: [11C]LY274601","volume":"63","author":"Suehiro","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2007.07.008_bib101","first-page":"563","article-title":"Synthesis and evaluation of 5-HT1A agonists as radioligands: failure of G protein-coupled receptor agonists as in vivo imaging agents","volume":"40","author":"Mathis","year":"1997","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib102","first-page":"S179","article-title":"(R)-[N-11C-methyl]-11-hydroxy-10-methylaporphine as a ligand for 5-HT1A receptors: synthesis and evaluation of its biodistribution in monkey with PET","volume":"44","author":"Thorell","year":"1995","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib103","first-page":"163P","article-title":"Synthesis and biodistribution of [C-11]Org-13502, a high-affinity serotonin (5-HT1A) receptor ligand","volume":"36","author":"Barf","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.drudis.2007.07.008_bib104","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0969-8051(02)00305-0","article-title":"Synthesis and evaluation of 11C-labeled (S)-N-{[1-(2-phenylethyl) pyrrolidin-2-yl]methyl}-3-methylthiobenzamide as a PET 5-HT1A receptor ligand","volume":"29","author":"Fujio","year":"2002","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib105","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1002\/jlcr.2580440162","article-title":"1-[2[(4-[F-18]fluorobenzamido-1-ethyl]4-(1,2,3,4-tetrahydronaphth-1-yl)-piperidine (FBP)","volume":"44","author":"Hwang","year":"2001","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib106","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jlcr.837","article-title":"Synthesis and preliminary in vivo evaluation of 4-[18F]fluoro-N-{2-[4-(6-trifluoromethylpyridin-2-yl)piperazin-1-yl]ethyl}benzamide, a potential PET radioligand for the 5-HT1A receptor","volume":"47","author":"Vandecapelle","year":"2004","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib107","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0969-8051(01)00223-2","article-title":"In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor","volume":"28","author":"Vandecapelle","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0969-8051(03)00027-1","article-title":"Carbon-11 labelling of 8{{3-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]-2-hydroxypropyl}oxy}thiochroman, a presynaptic 5-HT1A receptor agonist, and its in vivo evaluation in anaesthetized rat and in awake cat","volume":"30","author":"Zimmer","year":"2003","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.drudis.2007.07.008_bib109","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jlcr.1009","article-title":"Alternative methods for labeling the 5-HT1A receptor agonist, 1-[2-(4-fluorobenzoylamino)ethyl]-4-(7-methoxynaphthyl)piperazine (S14506), with carbon-11 or fluorine-18","volume":"48","author":"Lu","year":"2006","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.drudis.2007.07.008_bib110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1021\/jm050725j","article-title":"Synthesis and in vivo validation of [O-methyl-11C]-2-[4-[4-(7-methoxy-1-naphthalenyl)-1-piperazinyl]butyl]-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand","volume":"49","author":"Kumar","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2007.07.008_bib111","unstructured":"Kumar, J.S.D, and Mann, J.J. (2006) Radiolabeled piperizine compounds and uses thereof. WO 2006083424"},{"key":"10.1016\/j.drudis.2007.07.008_bib112","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.bmcl.2006.01.052","article-title":"Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: A novel agonist 5-HT1A receptor PET ligand","volume":"16","author":"Prabhakaran","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2007.07.008_bib113","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00259-006-0324-y","article-title":"Synthesis and in vivo Evaluation of 5-HT1A receptor Agonist Radioligand [O-methyl-11C]2-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)- dione in Nonhuman Primates","volume":"34","author":"Kumar","year":"2007","journal-title":"Eur. J. Nuc. Med. Mol. Imaging"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644607002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644607002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:59:26Z","timestamp":1761220766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644607002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":113,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1359644607002747"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2007.07.008","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET tracers for 5-HT1A receptors and uses thereof","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2007.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}